24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
(800)421-8825
Fax: (361)578-5500

Medical Disorders
Resources
Basic InformationLookupsLatest News
FDA Approves First Contact Lens That Slows Myopia ProgressionStatins Won't Harm Aging Brains, and May Even HelpGene Test Might Someday Gauge Your Cardiac Arrest RiskExpensive Device Used in Heart Surgeries Might Pose Dangers: StudyCheap, Older Gout Drug Could Be a Lifesaver After Heart AttackStudy Casts Doubt on Angioplasty, Bypass for Many Heart PatientsFasting Diet Could Benefit Heart Health: StudyFetroja Approved to Treat Complicated Urinary Tract InfectionsFlu Season Starting to Ramp Up in the SouthAHA News: Quitting Smoking Could Lead to Major Changes in Gut BacteriaHealth Tip: Do's and Don'ts for Calling 911Experimental Injection May Protect Against Peanut AllergyReblozyl Approved to Treat Anemia in Patients With Beta ThalassemiaAHA News: High Blood Pressure Common Among Black Young AdultsAHA News: Congenital Heart Disease Linked to Neighborhood Pollution, PovertySome Headway Made Against 'Superbugs,' but Threat Remains: CDCHealth Tip: A Well-Stocked First-Aid KitLung Cancer Report Delivers Good, Bad NewsAHA News: Millions Unaware of Common Heart Attack SymptomsWant Extra Years of Life? Keep Blood Pressure Tightly ControlledTestosterone Supplements Double Men's Odds for Blood Clots: StudyHealth Tip: Treating Post-Nasal DripOpioids Won't Help Arthritis Patients Long-Term: StudyCommon Muscle Relaxant Could Pose Mental Dangers for SeniorsKratom May Cause Liver Damage: StudySupplements Don't Prevent Kidney Disease in Type 2 DiabeticsNew Tool Predicts Odds of Kidney DiseaseVitamin E Acetate Is Leading Suspect in Vaping-Linked Lung Illnesses: CDCVaping-Linked Lung Illnesses Top 2,000, CDC SaysAHA News: Stroke Death Rate Increasing for Middle-Aged AmericansRural Americans Dying More From Preventable Causes Than City DwellersWhy Hand-Washing Beats Hand SanitizersSleepless Nights Could Raise Heart RisksScreening Truckers for Sleep Apnea Cuts Health Insurance CostsDo You Take Biotin Supplements? They Could Affect Your Medical TestsAHA News: Heart Disease Down Over A Generation Among American IndiansRisks Mount for Lonely Hearts After Cardiac SurgeryDaylight Saving Time Bad for Health, Experts ClaimHealth Tip: Prevent BloatingCould a Blood Test for Breast Cancer Become a Reality?One Dead, 8 Hospitalized in Salmonella Outbreak Tied to Ground BeefMost Americans Fear Cancer, but Feel Powerless to Prevent It: SurveyFewer Opioids After Eye Surgery Don't Mean More Post-Op PainDrug Trio Could Give Patients With Cystic Fibrosis a New OptionCould Tissue-Sealing Tape One Day Replace Stitches?Deep Sleep May 'Rinse' Day's Toxins From BrainClose to 1,900 Cases of Vaping-Linked Lung Illness, CDC SaysMeasles Leaves People More Vulnerable to Future InfectionsHealth Tip: Nausea After EatingSooner Is Usually Better for Gallbladder Surgery
Questions and AnswersLinks
Related Topics

Diabetes

For Men, Living Alone May Mean Poorer Control of Blood-Thinning Meds

HealthDay News
by -- Robert Preidt
Updated: Sep 3rd 2019

new article illustration

MONDAY, Sept. 2, 2019 (HealthDay News) -- Men who are on the blood-thinning drug warfarin have more difficulty taking the medication if they live alone, but the same is not true for women, a new study finds.

Warfarin (brand-name Coumadin) is a common anti-clotting treatment to prevent stroke in people with atrial fibrillation, the most common type of heart rhythm disorder.

Continuous blood-monitoring is required for warfarin to be safe and effective. Too little of the drug may allow a blood clot to form and cause a stroke. Too much causes bleeding.

Having ideal warfarin concentrations in the blood to prevent stroke and avoid bleeding is called time in therapeutic range (TTR). European Society of Cardiology (ESC) guidelines say patients should be in TTR at least 70% of the time.

In this study, researchers assessed nearly 4,800 patients in Denmark with six months of continuous warfarin use and monitoring. Median TTR in men living alone was 57% -- 3.6% lower than in men who lived with partners. (Median means half had longer times, half shorter.)

Women who lived alone had a 0.2% lower TTR than those who lived with partners, but the difference wasn't significant, according to the study authors.

The findings were presented Monday at the annual meeting of the ESC in Paris. Research presented at meetings is typically considered preliminary until published in a peer-reviewed journal.

"Men living alone had low, poor anticoagulation control. The impact of living on their own was larger than several factors previously known to affect TTR, such as cancer, use of interacting medication or heart failure," study author Dr. Anders Bonde said in an ESC news release.

"'Ask my wife' is a common reply among older men to questions about their medication, disease and treatment," he noted.

"Our study suggests that when it comes to anticoagulation control, men are more dependent on their partner than women," said Bonde, who practices at Gentofte University Hospital in Copenhagen, Denmark.

He added that women living alone often have better relationships with their children and a broader network of people around them.

Bonde suggested that men who live alone and use warfarin may need extra support -- such as education, home visits, telephone calls or additional follow-up visits -- or another medication.

"They might also consider using a newer type of drug, a non-vitamin K antagonist oral anticoagulant [such as Pradaxa or Eliquis], which is easier to manage and has fewer interactions with food and drugs compared to warfarin," Bonde said.

More information

The American Heart Association has more on atrial fibrillation medications.